How Technology Is Changing the Treatment Paradigm: An Overview of Technological Tools to Manage Diabetes

ONLINEEnduring MaterialAMA



Date & Location
Sunday, June 26, 2022, 12:00 AM - Monday, June 26, 2023, 12:00 PM

Overview

This online lecture provides physicians and other healthcare practitioners updates on current issues related to healthcare. The lecture will be maximum of one hour in length, followed by post test. Participants will have the opportunity to learn about the differences between types of insulin pumps and automated insulin delivery, distinguish between categories of continuous glucose monitors and how it informs patient selection and define several key metrics in an Ambulatory Glucose Profile (AGP report).

  • Release Date: June 26, 2022
  • End Date: June 26, 2023

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Researchers, Students

Overall Learning Objective
  1. Discuss the differences between types of insulin pumps and automated insulin delivery
  2. Distinguish between categories of continuous glucose monitors and how it informs patient selection
  3. Define several key metrics in an Ambulatory Glucose Profile (AGP report)

Registration
FREE of charge

Accreditation

The Ministry of Public Health's Department of Healthcare Professions (DHP) considers Asynchronous activities under Category 2 as self-directed learning.  

 
Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to the Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Bibliography:

1. Ahn, David T., and Rachel Stahl. "Is there an app for that? The pros and cons of diabetes smartphone apps and how to integrate them into clinical practice." Diabetes Spectrum 32.3 (2019): 231-236.

2. American Diabetes Association. (2022). 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022. Diabetes Care, 45(Supplement_1), S.83-S96.

3. American Diabetes Association. (2022). 7. Diabetes technology: standards of medical care in diabetes—2022. Diabetes Care, 45(Supplement 1), S97-S112.

4. American Diabetes Association (2022). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022. Diabetes Care 1 January 2022; 45 (Supplement_1): S125–S143

5. Berget, Cari, Laurel H. Messer, and Gregory P. Forlenza. "A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy." Diabetes Spectrum 32.3 (2019): 194-204

6. Danne T et al. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017;40:1631-1640.

7. Huckvale K, Adomaviciute S, Prieto JT, Leow MK, Car J. Smartphone apps for calculating insulin dose: a systematic assessment. BMC Med 2015;13:106

8. Haynes, Sarah C., et al. "Factors Associated With Discontinuation of Subspecialty Diabetes Care During the COVID-19 Pandemic: A Multisite Retrospective Cohort Study." Diabetes care 45.2 (2022): e34-e36.

9. Longo, Rebecca, and Scott Sperling. "Personal versus professional continuous glucose monitoring: when to use which on whom." Diabetes Spectrum 32.3 (2019): 183-193.